WO2001010434A1 - Pharmaceutical compositions containing n-palmitoylethanolamide and use thereof in the veterinary field - Google Patents

Pharmaceutical compositions containing n-palmitoylethanolamide and use thereof in the veterinary field Download PDF

Info

Publication number
WO2001010434A1
WO2001010434A1 PCT/IT1999/000259 IT9900259W WO0110434A1 WO 2001010434 A1 WO2001010434 A1 WO 2001010434A1 IT 9900259 W IT9900259 W IT 9900259W WO 0110434 A1 WO0110434 A1 WO 0110434A1
Authority
WO
WIPO (PCT)
Prior art keywords
palmitoylethanolamide
treatment
micronized
pharmaceutical compositions
compositions containing
Prior art date
Application number
PCT/IT1999/000259
Other languages
English (en)
French (fr)
Inventor
Cristina Comelli
Maria Federica Della Valle
Francesco Della Valle
Gabriele Marcolongo
Original Assignee
Innovet Italia S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11333115&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2001010434(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innovet Italia S.R.L. filed Critical Innovet Italia S.R.L.
Priority to AT99939603T priority Critical patent/ATE290858T1/de
Priority to DK99939603T priority patent/DK1207870T3/da
Priority to DE69924304T priority patent/DE69924304T2/de
Priority to EP99939603A priority patent/EP1207870B1/en
Priority to ES99939603T priority patent/ES2239453T3/es
Priority to PCT/IT1999/000259 priority patent/WO2001010434A1/en
Priority to US10/030,060 priority patent/US6548550B1/en
Publication of WO2001010434A1 publication Critical patent/WO2001010434A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PCT/IT1999/000259 1999-08-06 1999-08-06 Pharmaceutical compositions containing n-palmitoylethanolamide and use thereof in the veterinary field WO2001010434A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AT99939603T ATE290858T1 (de) 1999-08-06 1999-08-06 N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
DK99939603T DK1207870T3 (da) 1999-08-06 1999-08-06 Farmaceutiske præparater, der indeholder N-palmitoylethanolamid og anvendelse deraf
DE69924304T DE69924304T2 (de) 1999-08-06 1999-08-06 N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
EP99939603A EP1207870B1 (en) 1999-08-06 1999-08-06 Pharmaceutical compositions containing n-palmitoylethanolamide and use thereof in the veterinary field
ES99939603T ES2239453T3 (es) 1999-08-06 1999-08-06 Composiciones farmaceuticas que contienen n-palmitoiletanolamida y uso de ellas en el campo veterinario.
PCT/IT1999/000259 WO2001010434A1 (en) 1999-08-06 1999-08-06 Pharmaceutical compositions containing n-palmitoylethanolamide and use thereof in the veterinary field
US10/030,060 US6548550B1 (en) 1999-08-06 1999-08-06 Pharmaceutical compositions containing N-palmitoylethanolamide and use thereof in the veterinary field

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT1999/000259 WO2001010434A1 (en) 1999-08-06 1999-08-06 Pharmaceutical compositions containing n-palmitoylethanolamide and use thereof in the veterinary field

Publications (1)

Publication Number Publication Date
WO2001010434A1 true WO2001010434A1 (en) 2001-02-15

Family

ID=11333115

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT1999/000259 WO2001010434A1 (en) 1999-08-06 1999-08-06 Pharmaceutical compositions containing n-palmitoylethanolamide and use thereof in the veterinary field

Country Status (7)

Country Link
US (1) US6548550B1 (und)
EP (1) EP1207870B1 (und)
AT (1) ATE290858T1 (und)
DE (1) DE69924304T2 (und)
DK (1) DK1207870T3 (und)
ES (1) ES2239453T3 (und)
WO (1) WO2001010434A1 (und)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011027373A1 (en) * 2009-09-07 2011-03-10 Epitech Group S.R.L. Composition containing ultra-micronized palmitoyl - ethanolamide
EP1406576B2 (en) † 2001-07-18 2011-06-29 Unilever PLC Hair and/or scalp treatment compositions
WO2016146453A1 (en) 2015-03-16 2016-09-22 Vanderbilt Science Holding Ltd Composition for use in the treatment of neuropathic pain
NL2017559B1 (en) * 2016-09-30 2018-04-10 Vanderbilt Science Holding Ltd Method for preparing pulverized palmitoylethanolamide particles, particles obtainable by the method, and apharmaceutical or neutraceutical composition comprising saidparticles

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI250023B (en) * 2001-10-22 2006-03-01 Santen Pharmaceutical Co Ltd Pharmaceutical composition for itch treating agent
CA2707546A1 (en) * 2007-12-06 2009-06-11 Unilever Plc Personal care composition
ES2648051T3 (es) * 2010-10-04 2017-12-28 Epitech Group S.P.A. Uso de amidas de ácidos mono y dicarboxílicos en el tratamiento de enfermedades renales
ITMI20131132A1 (it) 2013-07-05 2015-01-06 Epitech Group Srl Uso in combinazione di amidi di acidi mono- e dicarbossilici e silimarina nel trattamento di patologie renali
EP2921167B1 (en) 2014-03-19 2016-08-17 EPITECH GROUP S.p.A. Pharmaceutical composition comprising palmitoylethanolamide and l-acetylcarnitine
PT2944309T (pt) 2014-05-14 2019-06-05 Epitech Group S P A Utilização de palmitoiletanolamida em combinação com opióides
DK2965765T3 (da) 2014-07-08 2019-07-22 Epitech Group S P A Anvendelse af adelmidrol til behandling af epiteldysfunktioner
EP2985037B1 (en) 2014-08-13 2017-06-21 EPITECH GROUP S.p.A. A pharmaceutical composition comprising palmitoylethanolamid and cytidine-diphosphocholine
WO2016183134A1 (en) * 2015-05-12 2016-11-17 Cutting Edge Medical Solutions, Llc Palmitoylethanolamide compositions
IT202000007831A1 (it) 2020-04-14 2021-10-14 Epitech Group S P A Adelmidrol per l’uso nel trattamento della fibrosi polmonare
IT202100024464A1 (it) * 2021-09-23 2023-03-23 Epitech Group S P A N-palmitoil-etanolamide e acido docosaesaenoico per l’uso nel trattamento del disturbo dello spettro autistico e di altre sindromi depressive
EP4331577A1 (en) 2022-08-30 2024-03-06 Unifarco S.p.A. A nutraceutic tablet comprising palmitoylethanolamide

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0550006A2 (en) * 1991-12-31 1993-07-07 LIFEGROUP S.p.A. Use of N-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells
EP0550008A2 (en) * 1991-12-31 1993-07-07 LIFEGROUP S.p.A. Use of N-acyl derivatives of aminoalcohols with polycarboxylic acids for the manufacture of a medicament for the treatment of pathologies relating to mast cells
WO1996018391A2 (en) * 1994-12-14 1996-06-20 Lifegroup S.P.A. Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
WO1997010712A1 (en) * 1995-09-19 1997-03-27 Margolin Solomon B Inhibition of tumor necrosis factor alpha

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0550006A2 (en) * 1991-12-31 1993-07-07 LIFEGROUP S.p.A. Use of N-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells
EP0550008A2 (en) * 1991-12-31 1993-07-07 LIFEGROUP S.p.A. Use of N-acyl derivatives of aminoalcohols with polycarboxylic acids for the manufacture of a medicament for the treatment of pathologies relating to mast cells
WO1996018391A2 (en) * 1994-12-14 1996-06-20 Lifegroup S.P.A. Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
WO1997010712A1 (en) * 1995-09-19 1997-03-27 Margolin Solomon B Inhibition of tumor necrosis factor alpha

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MAZZARI S ET AL: "N-(2-HYDROXYETHYL)HEXADECANAMIDE IS ORALLY ACTIVE IN REDUCING EDEMA FORMATION AND INFLAMMATORY HYPERALGESIA BY DOWN-MODULATING MAST CELL ACTIVATION", EUROPEAN JOURNAL OF PHARMACOLOGY,NL,AMSTERDAM, vol. 300, no. 3, 1 January 1996 (1996-01-01), pages 227 - 236, XP000573451, ISSN: 0014-2999 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1406576B2 (en) † 2001-07-18 2011-06-29 Unilever PLC Hair and/or scalp treatment compositions
US8663701B2 (en) 2009-09-07 2014-03-04 Epitech Group S.R.L. Compositions containing ultra-micronized palmitoyl-ethanolamide
EP2796129B1 (en) 2009-09-07 2015-06-17 Epitech Group S.r.l. Composition containing ultra - micronized palmitoyl - ethanolamide
KR20120093861A (ko) * 2009-09-07 2012-08-23 에피테크 그룹 에스.알.엘. 초미세화 팔미토일-에탄올아미드를 함유한 조성물
JP2013503855A (ja) * 2009-09-07 2013-02-04 エピテック・グループ・エス．アール．エル． 超微粉化パルミトイル−エタノールアミドを含む組成物
US8470373B2 (en) 2009-09-07 2013-06-25 Epitech Group S.R.L. Composition containing ultra-micronized palmitoyl-ethanolamide
WO2011027373A1 (en) * 2009-09-07 2011-03-10 Epitech Group S.R.L. Composition containing ultra-micronized palmitoyl - ethanolamide
EP2796129A1 (en) * 2009-09-07 2014-10-29 Epitech Group S.r.l. Composition containing ultra - micronized palmitoyl - ethanolamide
CN102186459A (zh) * 2009-09-07 2011-09-14 晶源集团股份责任有限公司 含有超微粒化十六酰胺乙醇的组合物
EP2475352B1 (en) 2009-09-07 2015-06-17 Epitech Group S.r.l. Composition containing ultra-micronized palmitoyl - ethanolamide
AU2009352080B2 (en) * 2009-09-07 2015-12-24 Epitech Group S.P.A. Composition containing ultra-micronized palmitoyl - ethanolamide
CN106138022A (zh) * 2009-09-07 2016-11-23 晶源集团有限公司 含有超微粒化十六酰胺乙醇的组合物
KR101662871B1 (ko) 2009-09-07 2016-10-05 에피테크 그룹 에스.알.엘. 초미세화 팔미토일-에탄올아미드를 함유한 조성물
WO2016146453A1 (en) 2015-03-16 2016-09-22 Vanderbilt Science Holding Ltd Composition for use in the treatment of neuropathic pain
NL2017559B1 (en) * 2016-09-30 2018-04-10 Vanderbilt Science Holding Ltd Method for preparing pulverized palmitoylethanolamide particles, particles obtainable by the method, and apharmaceutical or neutraceutical composition comprising saidparticles

Also Published As

Publication number Publication date
DK1207870T3 (da) 2005-08-01
ES2239453T3 (es) 2005-09-16
EP1207870B1 (en) 2005-03-16
ATE290858T1 (de) 2005-04-15
DE69924304D1 (de) 2005-04-21
EP1207870A1 (en) 2002-05-29
US6548550B1 (en) 2003-04-15
DE69924304T2 (de) 2006-04-13

Similar Documents

Publication Publication Date Title
US6548550B1 (en) Pharmaceutical compositions containing N-palmitoylethanolamide and use thereof in the veterinary field
US5296476A (en) Skin care compositions
EP3435973B1 (en) Apremilast pharmaceutical compositions
CA2762013A1 (en) Granulation of pirfenidone and pharmaceutically acceptable excipients
JP2002511860A (ja) 皮膚の老化およびシワを治療および予防するためのイソフラボノイド
EP0666750A1 (en) Mixtures or complexes containing calcium and sulfate
JP2004513095A (ja) 疾患軽減製剤
JP2003530349A (ja) 皮膚病用の使用方法及び皮膚病用薬剤
EP0784975A1 (en) Use of acetylsalicylic acid in the manufacture of a drug for the treatment of skin injuries
JPS6041658A (ja) 新規アミノ酸誘導体の製法
DE2548367A1 (de) Heilmittel und verfahren zu seiner herstellung
JPH03294230A (ja) 子宮内膜症治療剤
JPH10175854A (ja) 津液改善用皮膚外用剤
JP2563158B2 (ja) ノナテトラエン酸誘導体
JPH10120558A (ja) 津液改善用皮膚外用剤
DE19815411A1 (de) Thermogenese stimulierend wirksame Arzneimittel
JP4421847B2 (ja) 脂肪分解促進剤
JP2016210703A (ja) 時計遺伝子発現促進用組成物
JPH0948732A (ja) 活性酸素消去剤及びそれを含む組成物
JPH10298055A (ja) 抗アンドロゲン剤及び養毛剤，皮脂分泌抑制剤
JPH10114650A (ja) 津液改善剤及びそれを含有する経口投与用組成物
EP0207421B1 (de) Verwendung eines Retinoids zur Herstellung eines antikeratinisierenden Arzneimittels
JP2005194239A (ja) セラミド合成促進剤及び皮膚外用剤
JP3178763B2 (ja) シムノールサルフェート製造法
EP0492747A2 (en) Pharmaceutical preparation for topical application

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1999939603

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10030060

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999939603

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1999939603

Country of ref document: EP